About TRANSCEND-T2D-1 and the TRANSCEND-T2D clinical trial program TRANSCEND-T2D-1 (NCT06354660) is a Phase 3, 40-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone
Lifestyle Factors and Weight Loss Success Importance of a Balanced Diet A balanced diet is crucial for maximising weight loss and achieving long-term results, particularly when using GLP-1 medications
Where should this page link next
I dont have that evidence because that trial has never happened and, as Ill explain in a minute, may never happen at all
Yes, adverse effects may include pain, redness, or swelling at the injection site
If youre already prescribed a GLP-1 elsewhere, Healthspan can support your care through membership